GSK, University of Oxford and Imperial College London launch centre to create computer models of lungs, liver, kidneys and cartilage

Published on March 19, 2026

A new research centre backed with £11 million from GSK will build open-source digital twins of organs for in-silico research to advance disease understanding and speed up development of new drugs.
Continue reading on website
Other news

Cambridge cancer expert leads development of new NICE guideline on kidney cancer

March 19, 2026
The guideline, published today by the National Institute for Health and Care Excellence (NICE), promotes the gold standard approach to the management of kidney cancer across all stages of the disease.The new recommendations aim to improve kidney cancer care across the NHS by helping healthcare professionals offer people the right treatments and support, while considering individual preferences.Pro

Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment

March 19, 2026
Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.